On March 8, 2019 Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with a pipeline of immune modulating antibodies, cancer vaccines, adjuvants and adoptive cell therapies1,reported that it will release its fourth quarter and full year 2018 financial results before the market opens on Thursday, March 14, 2019 (Press release, Agenus, MAR 8, 2019, https://www.prnewswire.com/news-releases/agenus-to-report-fourth-quarter-and-full-year-2018-financial-results-on-march-14-2019-and-host-conference-call-and-webcast-300808784.html [SID1234534149]). In connection with the earnings release, Agenus executives will host a conference call and live webcast at 8:30 a.m. ET the same day to discuss the results and provide Company updates.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Conference Call and Webcast Information:
Date: Thursday, March 14, 2019
Time: 8:30 a.m. ET
Domestic Dial-in Number: 1-844-492-3727
International Dial-in Number: 1-412-317-5118
Conference ID: Agenus
Live Webcast: accessible from the Company’s website at View Source or with this link View Source
A replay will be available on the Company’s website approximately two hours after the call and will remain available for 90 days.